Yoon Y - Search Results

1

Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.

Wu R, Yu W, Yao C, Liang Z, Yoon Y, Xie Y, Shim H, Bai R. Wu R, et al. Among authors: yoon y. Eur J Med Chem. 2020 Jan 1;185:111823. doi: 10.1016/j.ejmech.2019.111823. Epub 2019 Oct 30. Eur J Med Chem. 2020. PMID: 31698158

2

Silencing of CXCR4 blocks breast cancer metastasis.

Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L, Shim H. Liang Z, et al. Among authors: yoon y. Cancer Res. 2005 Feb 1;65(3):967-71. Cancer Res. 2005. PMID: 15705897 Free PMC article.

3

Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.

Shim H, Lau SK, Devi S, Yoon Y, Cho HT, Liang Z. Shim H, et al. Among authors: yoon y. Biochem Biophys Res Commun. 2006 Jul 21;346(1):252-8. doi: 10.1016/j.bbrc.2006.05.110. Epub 2006 May 26. Biochem Biophys Res Commun. 2006. PMID: 16756955

4

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.

Liang Z, Brooks J, Willard M, Liang K, Yoon Y, Kang S, Shim H. Liang Z, et al. Among authors: yoon y. Biochem Biophys Res Commun. 2007 Aug 3;359(3):716-22. doi: 10.1016/j.bbrc.2007.05.182. Epub 2007 Jun 4. Biochem Biophys Res Commun. 2007. PMID: 17559806 Free PMC article.

5

CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.

Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, Cho HT, Shin DM, Goodman MM, Chen ZG, Shim H. Yoon Y, et al. Cancer Res. 2007 Aug 1;67(15):7518-24. doi: 10.1158/0008-5472.CAN-06-2263. Cancer Res. 2007. PMID: 17671223

6

Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.

Liang Z, Wu H, Reddy S, Zhu A, Wang S, Blevins D, Yoon Y, Zhang Y, Shim H. Liang Z, et al. Among authors: yoon y. Biochem Biophys Res Commun. 2007 Nov 23;363(3):542-6. doi: 10.1016/j.bbrc.2007.09.007. Epub 2007 Sep 14. Biochem Biophys Res Commun. 2007. PMID: 17889832

7

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, Scala S, Shim H. Liang Z, et al. Among authors: yoon y. Biochem Pharmacol. 2010 Mar 15;79(6):817-24. doi: 10.1016/j.bcp.2009.10.017. Epub 2009 Oct 31. Biochem Pharmacol. 2010. PMID: 19883630

8

Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.

Zhu A, Zhan W, Liang Z, Yoon Y, Yang H, Grossniklaus HE, Xu J, Rojas M, Lockwood M, Snyder JP, Liotta DC, Shim H. Zhu A, et al. Among authors: yoon y. J Med Chem. 2010 Dec 23;53(24):8556-68. doi: 10.1021/jm100786g. Epub 2010 Nov 24. J Med Chem. 2010. PMID: 21105715 Free PMC article.

9

Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.

Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, Miller AH, Pace TW. Olivera A, et al. Among authors: yoon y. Int Immunopharmacol. 2012 Feb;12(2):368-77. doi: 10.1016/j.intimp.2011.12.009. Epub 2011 Dec 22. Int Immunopharmacol. 2012. PMID: 22197802 Free PMC article.

10

Early prediction of response to Vorinostat in an orthotopic rat glioma model.

Wei L, Hong S, Yoon Y, Hwang SN, Park JC, Zhang Z, Olson JJ, Hu XP, Shim H. Wei L, et al. Among authors: yoon y. NMR Biomed. 2012 Sep;25(9):1104-11. doi: 10.1002/nbm.2776. Epub 2012 Feb 2. NMR Biomed. 2012. PMID: 22302519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,303 results

Search Page